SCHEMBL21499716

SCHEMBL21499716

CC(C)S(=O)(=O)c1ccc(-c2nc3c(n2Cc2ccccc2)C(=O)N(CCCO)C(O)N3C)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 2/20 0.38
▸ PDE4B Q07343 2/20 0.38
▸ PDE4C Q08493 2/20 0.38
▸ PDE4D Q08499 2/20 0.38
▸ PDE5A O76074 1/20 0.38
▸ PDE2A O00408 1/20 0.37
▸ PTGDR2 Q9Y5Y4 1/20 0.37
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ P2RX7 Q99572 4/20 0.35
▸ PTGS1 P23219 1/20 0.35
▸ PTGS2 P35354 1/20 0.35
▸ ADORA3 P0DMS8 2/20 0.35
▸ LMNA P02545 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ BRD4 O60885 1/20 0.34
▸ F11 P03951 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22105398 0.84 MEN1 (0.50) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL21316344 0.83 P2RX3 (0.40) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL18835033 0.81 USP1 (0.39) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL21316348 0.80 ALDH1A1 (0.40) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL18834975 0.79 KDM4E (0.39) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL19505584 0.79 P2RX7 (0.39) MEN1KMT2AALDH1A1P2RX7TSHR
SCHEMBL18834253 0.79 ADORA3 (0.46) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL18834259 0.78 P2RX3 (0.39) —
SCHEMBL21499640 0.78 MDM2 (0.38) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL18835230 0.76 ALDH1A1 (0.41) MEN1KMT2AALDH1A1P2RX7LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF HYDRA BIOSCIENCES, LLC (US) 2023-02-09 — — US disclosed
US-11208409-B2 Substituted xanthines and methods of use thereof HYDRA BIOSCIENCES, LLC (US) 2021-12-28 — — US disclosed
US-20190322667-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2019-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230040259-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 PDE4A 615/4885PDE4B 583/4885PDE4C 411/4885
US-11208409-B2 Substituted xanthines and methods of use thereof TRPC5, TRPC7, TRPC4 PDE4A 615/4885PDE4B 583/4885PDE4C 411/4885
US-20190322667-A1 SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF TRPC5, TRPC7, TRPC4 PDE4A 615/4885PDE4B 583/4885PDE4C 411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback